Pfizer BioNTech

Amid COVID-19's new variant, Omicron concern, the US Food and Drug Administration approved booster doses against Covid-19, to 16 &17 year olds. Approved on December 9, Pfizer/BioNTech are to be taken after six months of their second dose. ''Initial data suggests that COVID-19 boosters help strengthen the protection against Omicron,'' said Rochelle Walenskyy, Director of Central Disease Control (CDC). In the US, 2.5 million people are… read-more